Muscle Relaxant Drug Market
PUBLISHED: 2024 ID: SMRC24739
SHARE
SHARE

Muscle Relaxant Drug Market

Muscle Relaxant Drug Market Forecasts to 2030 - Global Analysis By Drug Type (Neuromuscular Blocking Agents, Skeletal Muscle Relaxant Drugs and Facial Muscle Relaxant Drugs), Dosage Form (Capsule, Tablet, Liquid, Sprays and Gel and Ointments), Route Of Administration, Distribution Channel, Application, End User and By Geography

4.9 (36 reviews)
4.9 (36 reviews)
Published: 2024 ID: SMRC24739

This report covers the impact of COVID-19 on this global market
Loading...

Years Covered

2021-2030

Estimated Year Value (2023)

US $3.9 BN

Projected Year Value (2030)

US $6.03 BN

CAGR (2023 - 2030)

6.3%

Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

Asia Pacific

Highest Growing Market

Europe


According to Stratistics MRC, the Global Muscle Relaxant Drug Market is accounted for $3.9 billion in 2023 and is expected to reach $6.03 billion by 2030 growing at a CAGR of 6.3% during the forecast period. Muscle relaxant drugs act on the central nervous system, targeting neuromuscular junctions, the spinal cord, or specific areas of the brain to modulate signals involved in muscle contraction. Muscle relaxants are effective in providing relief from musculoskeletal pain associated with conditions such as strains, sprains, and injuries. These drugs are utilized in various medical conditions, including the management of conditions such as spasticity resulting from neurological disorders, musculoskeletal injuries, and certain types of chronic pain.

According to a study of Global Burden of Disease (GBD) 2021 data, 1.71 billion individuals globally suffer from musculoskeletal diseases, such as osteoarthritis, rheumatoid arthritis, neck discomfort, low back pain, fractures, and other injuries.

Market Dynamics: 

Driver: 

Growing geriatric population

The growing geriatric population is a significant driver in the muscle relaxant drug market, accelerating the demand. As the global population ages, there is an increased prevalence of age-related musculoskeletal conditions, such as arthritis, chronic pain, and degenerative disorders. These conditions often result in muscle stiffness, spasms, and discomfort, requiring medical intervention for pain relief and improved mobility. Muscle relaxant drugs play a crucial role in addressing these needs by providing relief from muscle spasms, reducing pain and improving physical function.

Restraint:

Side effects

The prevalence of side effects associated with muscle relaxant drugs stands as a substantial restraint in the muscle relaxant drug market, hampering its growth. Common side effects include drowsiness, dizziness, and potential interactions with other medications, impacting patient adherence and overall satisfaction with treatment. However, safety concerns surrounding muscle relaxants can lead to hesitancy among healthcare providers in prescribing these drugs, especially to certain patient populations, such as the elderly or those with co-morbidities.

Opportunity:

Rising prevalence of sedentary lifestyles

The increasing prevalence of sedentary lifestyles serves as a significant driver for the muscle relaxant drug market. Modern societal trends, characterized by prolonged periods of sitting, desk-bound work and limited physical activity, contribute to a rise in musculoskeletal issues. Furthermore, sedentary lifestyles are linked to conditions such as muscle spasms, strains, and chronic pain, necessitating the use of muscle relaxant drugs for symptomatic relief, which enhances market demand.

Threat:

Availability of alternative treatment modalities

Patients and healthcare providers increasingly explore non-pharmacological interventions, such as physical therapy, acupuncture, and exercise regimens, as viable alternatives to muscle relaxant drugs. Moreover, patients are becoming more proactive in seeking therapies that promote overall well-being and mitigate the need for pharmacological interventions. The availability of alternative treatment modalities is a significant restraint hindering market expansion.

Covid-19 Impact

The initial phase of the pandemic led to disruptions in the pharmaceutical supply chain, affecting the production and distribution of muscle relaxant drugs. However, as healthcare systems adapted to the evolving circumstances, the market witnessed a resurgence driven by the need for effective pain management and muscle-related interventions. The pandemic-induced lifestyle changes, including increased sedentary behaviors and stress-related muscle tension, contributed to a sustained demand for muscle relaxant medications.

The Injectable segment is expected to be the largest during the forecast period

The Injectable segment is estimated to hold the largest share. The Injectable route of administration plays a pivotal role in the delivery of therapeutic agents designed to induce muscle relaxation. Injectable muscle relaxants are administered directly into the bloodstream or targeted muscle tissues through methods such as intramuscular or intravenous injections. This route offers several advantages, including a quick onset of action and accurate dosage control, which enhances the demand for muscle relaxant drugs.

The skeletal muscle relaxant drugs segment is expected to have the highest CAGR during the forecast period

The skeletal muscle relaxant drugs segment is anticipated to have lucrative growth during the forecast period. These drugs act on the central nervous system, either at the spinal cord or brain levels, to alleviate muscle spasms, stiffness, and associated discomfort. The therapeutic applications of skeletal muscle relaxants are diverse, ranging from the management of musculoskeletal conditions and spasticity to facilitating surgical procedures and promoting physical therapy outcomes. Moreover, in surgical settings, skeletal muscle relaxants find utility as adjuncts to anaesthesia, facilitating intubation and minimizing involuntary muscle movements during procedures.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to rising prevalence of musculoskeletal disorders and increasing awareness and accessibility to healthcare services. The Asia-Pacific region's diverse healthcare landscape witnesses a growing acceptance of non-invasive treatment modalities, including muscle relaxants, both for therapeutic and cosmetic purposes. Additionally, the region's economic development results in an increasing capacity for healthcare spending, supporting the adoption of innovative pharmaceutical solutions.

Region with highest CAGR:

Europe is expected to witness profitable growth over the projection period, due to robust healthcare infrastructure, technological advancements, and a high prevalence of musculoskeletal disorders. The region's aging population contributes significantly to the demand for muscle relaxant drugs as age-related conditions, such as arthritis and muscle stiffness, become more prevalent. Moreover, the region's healthcare systems prioritize patient-centric care, contributing to the exploration of innovative treatment options for musculoskeletal conditions.

Key players in the market

Some of the key players in the Muscle Relaxant Drug Market include Mylan, Novartis AG, Ipsen Biopharmaceuticals, Inc., Pfizer Inc, Merz Pharmaceuticals, LLC., Vertical Pharmaceuticals, Amneal Pharmaceuticals LLC, Sanofi, Teva Pharmaceuticals Industries Ltd, Inc., Par Pharmaceutical, Sun Pharmaceutical Industries Ltd., Abbott Laboratories and F. Hoffmann-La Roche AG.  

Key Developments:

In Mar 2023, Abbott partners with Medinbox to increase efficiency in electrophysiology labs and strengthen information sharing among physicians to drive improved patient care.

In June 2022, Novartis announced a partnership with the American Society of Hematology (ASH) to provide six additional African nations with technology that is already being used in Ghana to document and share the diagnosis of babies with sickle cell disease.

In January 2021, Novartis announced collaboration with Alnylam to leverage Alnylam’s proven, proprietary siRNA technology to inhibit a target discovered at the Novartis Institutes for BioMedical Research, potentially leading to development of a treatment designed to promote the regrowth of functional liver cells and to provide an alternative to transplantation for patients with liver failure.

Drug Types Covered:
• Neuromuscular Blocking Agents  
• Skeletal Muscle Relaxant Drugs  
• Facial Muscle Relaxant Drugs  

Dosage Forms Covered:
• Capsule 
• Tablet 
• Liquid 
• Sprays 
• Gel and Ointments 

Route Of Administrations Covered:
• Injectable
• Oral
• Other Route Of Administration

Distribution Channels Covered:
• Retail Pharmacy 
• Online Pharmacy 
• Hospital Pharmacy 

Applications Covered:
• Musculoskeletal Disorders 
• Muscle Spasm & Pain Relief 
• Surgery 
• Other Applications 

End Users Covered:
• Specialty Clinics 
• Hospitals 
• Homecare 
• Other End Users 

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary           
            
2 Preface           
 2.1 Abstract          
 2.2 Stake Holders          
 2.3 Research Scope          
 2.4 Research Methodology          
  2.4.1 Data Mining         
  2.4.2 Data Analysis         
  2.4.3 Data Validation         
  2.4.4 Research Approach         
 2.5 Research Sources          
  2.5.1 Primary Research Sources         
  2.5.2 Secondary Research Sources         
  2.5.3 Assumptions         
            
3 Market Trend Analysis           
 3.1 Introduction          
 3.2 Drivers          
 3.3 Restraints          
 3.4 Opportunities          
 3.5 Threats          
 3.6 Application Analysis          
 3.7 End User Analysis          
 3.8 Emerging Markets          
 3.9 Impact of Covid-19          
            
4 Porters Five Force Analysis           
 4.1 Bargaining power of suppliers          
 4.2 Bargaining power of buyers          
 4.3 Threat of substitutes          
 4.4 Threat of new entrants          
 4.5 Competitive rivalry          
            
5 Global Muscle Relaxant Drug Market, By Drug Type           
 5.1 Introduction          
 5.2 Neuromuscular Blocking Agents          
 5.3 Skeletal Muscle Relaxant Drugs          
 5.4 Facial Muscle Relaxant Drugs          
            
6 Global Muscle Relaxant Drug Market, By Dosage Form           
 6.1 Introduction          
 6.2 Capsule          
 6.3 Tablet          
 6.4 Liquid          
 6.5 Sprays          
 6.6 Gel and Ointments          
            
7 Global Muscle Relaxant Drug Market, By Route Of Administration           
 7.1 Introduction          
 7.2 Injectable          
 7.3 Oral          
 7.4 Other Route Of Administration          
            
8 Global Muscle Relaxant Drug Market, By Distribution Channel           
 8.1 Introduction          
 8.2 Retail Pharmacy          
 8.3 Online Pharmacy          
 8.4 Hospital Pharmacy          
            
9 Global Muscle Relaxant Drug Market, By Application           
 9.1 Introduction          
 9.2 Musculoskeletal Disorders          
 9.3 Muscle Spasm & Pain Relief          
 9.4 Surgery          
 9.5 Other Applications          
            
10 Global Muscle Relaxant Drug Market, By End User           
 10.1 Introduction          
 10.2 Specialty Clinics          
 10.3 Hospitals          
 10.4 Homecare          
 10.5 Other End Users          
            
11 Global Muscle Relaxant Drug Market, By Geography           
 11.1 Introduction          
 11.2 North America          
  11.2.1 US         
  11.2.2 Canada         
  11.2.3 Mexico         
 11.3 Europe          
  11.3.1 Germany         
  11.3.2 UK         
  11.3.3 Italy         
  11.3.4 France         
  11.3.5 Spain         
  11.3.6 Rest of Europe         
 11.4 Asia Pacific          
  11.4.1 Japan         
  11.4.2 China         
  11.4.3 India         
  11.4.4 Australia         
  11.4.5 New Zealand         
  11.4.6 South Korea         
  11.4.7 Rest of Asia Pacific         
 11.5 South America          
  11.5.1 Argentina         
  11.5.2 Brazil         
  11.5.3 Chile         
  11.5.4 Rest of South America         
 11.6 Middle East & Africa          
  11.6.1 Saudi Arabia         
  11.6.2 UAE         
  11.6.3 Qatar         
  11.6.4 South Africa         
  11.6.5 Rest of Middle East & Africa         
            
12 Key Developments           
 12.1 Agreements, Partnerships, Collaborations and Joint Ventures          
 12.2 Acquisitions & Mergers          
 12.3 New Product Launch          
 12.4 Expansions          
 12.5 Other Key Strategies          
            
13 Company Profiling           
 13.1 Mylan           
 13.2 Novartis AG          
 13.3 Ipsen Biopharmaceuticals, Inc.          
 13.4 Pfizer Inc          
 13.5 Merz Pharmaceuticals, LLC.          
 13.6 Vertical Pharmaceuticals          
 13.7 Amneal Pharmaceuticals LLC          
 13.8 Sanofi          
 13.9 Teva Pharmaceuticals Industries Ltd, Inc.          
 13.10 Par Pharmaceutical          
 13.11 Sun Pharmaceutical Industries Ltd.          
 13.12 Abbott Laboratories          
 13.13 F. Hoffmann-La Roche AG          
            
List of Tables            
1 Global Muscle Relaxant Drug Market Outlook, By Region (2021-2030) ($MN)           
2 Global Muscle Relaxant Drug Market Outlook, By Drug Type (2021-2030) ($MN)           
3 Global Muscle Relaxant Drug Market Outlook, By Neuromuscular Blocking Agents (2021-2030) ($MN)           
4 Global Muscle Relaxant Drug Market Outlook, By Skeletal Muscle Relaxant Drugs (2021-2030) ($MN)           
5 Global Muscle Relaxant Drug Market Outlook, By Facial Muscle Relaxant Drugs (2021-2030) ($MN)           
6 Global Muscle Relaxant Drug Market Outlook, By Dosage Form (2021-2030) ($MN)           
7 Global Muscle Relaxant Drug Market Outlook, By Capsule (2021-2030) ($MN)           
8 Global Muscle Relaxant Drug Market Outlook, By Tablet (2021-2030) ($MN)           
9 Global Muscle Relaxant Drug Market Outlook, By Liquid (2021-2030) ($MN)           
10 Global Muscle Relaxant Drug Market Outlook, By Sprays (2021-2030) ($MN)           
11 Global Muscle Relaxant Drug Market Outlook, By Gel and Ointments (2021-2030) ($MN)           
12 Global Muscle Relaxant Drug Market Outlook, By Route Of Administration (2021-2030) ($MN)           
13 Global Muscle Relaxant Drug Market Outlook, By Injectable (2021-2030) ($MN)           
14 Global Muscle Relaxant Drug Market Outlook, By Oral (2021-2030) ($MN)           
15 Global Muscle Relaxant Drug Market Outlook, By Other Route Of Administration (2021-2030) ($MN)           
16 Global Muscle Relaxant Drug Market Outlook, By Distribution Channel (2021-2030) ($MN)           
17 Global Muscle Relaxant Drug Market Outlook, By Retail Pharmacy (2021-2030) ($MN)           
18 Global Muscle Relaxant Drug Market Outlook, By Online Pharmacy (2021-2030) ($MN)           
19 Global Muscle Relaxant Drug Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)           
20 Global Muscle Relaxant Drug Market Outlook, By Application (2021-2030) ($MN)           
21 Global Muscle Relaxant Drug Market Outlook, By Musculoskeletal Disorders (2021-2030) ($MN)           
22 Global Muscle Relaxant Drug Market Outlook, By Muscle Spasm & Pain Relief (2021-2030) ($MN)           
23 Global Muscle Relaxant Drug Market Outlook, By Surgery (2021-2030) ($MN)           
24 Global Muscle Relaxant Drug Market Outlook, By Other Applications (2021-2030) ($MN)           
25 Global Muscle Relaxant Drug Market Outlook, By End User (2021-2030) ($MN)           
26 Global Muscle Relaxant Drug Market Outlook, By Specialty Clinics (2021-2030) ($MN)           
27 Global Muscle Relaxant Drug Market Outlook, By Hospitals (2021-2030) ($MN)           
28 Global Muscle Relaxant Drug Market Outlook, By Homecare (2021-2030) ($MN)           
29 Global Muscle Relaxant Drug Market Outlook, By Other End Users (2021-2030) ($MN)           
            
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above. 

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials